365 related articles for article (PubMed ID: 28272799)
1. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
[TBL] [Abstract][Full Text] [Related]
2. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
4. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
5. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
[TBL] [Abstract][Full Text] [Related]
6. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
7. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
10. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
12. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
[TBL] [Abstract][Full Text] [Related]
13. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
[TBL] [Abstract][Full Text] [Related]
14. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
[TBL] [Abstract][Full Text] [Related]
15. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
[TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
[TBL] [Abstract][Full Text] [Related]
19. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
20. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]